abstract |
The present invention provides a novel compound for the treatment of hyperproliferative diseases. A 5,6, or 7-substituted-3- (hetero) arylisoquinolinamine derivative represented by the general formula (I), a pharmaceutically acceptable salt thereof, and a composition containing the compound object. [Wherein R 1 , R 2 , R 3 , and R 4 represent a hydrogen atom, X represents a nitrogen atom, and n represents 0 or 1]. [Selection figure] None |